申请人:BOEHRINGER INGELHEIM INTERNATIONAL GMBH
公开号:US20130281430A1
公开(公告)日:2013-10-24
The invention relates to new amino-indole-substituted imidazolyl-pyrimidines of formula 1
wherein
R
1
, R
2
, R
3
, R
4
and R
5
are defined as in claim
1
and pharmaceutically acceptable salts thereof and the use of these compounds for the preparation of a medicament for treating a disease selected from asthma, COPD, rheumatoid arthritis, specific lymphomas and specific diseases of the nervous system.
该发明涉及新的氨基吲哚取代的咪唑基嘧啶化合物,化学式为1,其中R1、R2、R3、R4和R5如权利要求1所定义,以及其药学上可接受的盐,以及利用这些化合物制备用于治疗哮喘、慢性阻塞性肺疾病、类风湿性关节炎、特定淋巴瘤和特定神经系统疾病的药物。